Reaction-drivende novodesign, synthesis and testing of potential type II kinase inhibitors
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reaction-drivende novodesign, synthesis and testing of potential type II kinase inhibitors
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 3, Issue 4, Pages 415-424
Publisher
Future Science, LTD
Online
2011-03-31
DOI
10.4155/fmc.11.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological impact of freezing Plk1 in its inactive conformation in cancer cells
- (2011) Sarah Keppner et al. CELL CYCLE
- Self-organizing molecular fingerprints: a ligand-based view on drug-like chemical space and off-target prediction
- (2010) Gisbert Schneider et al. Future Medicinal Chemistry
- Predicting Polypharmacology by Binding Site Similarity: From Kinases to the Protein Universe
- (2010) Francesca Milletti et al. Journal of Chemical Information and Modeling
- Activity Landscape Representations for Structure−Activity Relationship Analysis
- (2010) Anne Mai Wassermann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Self-Organizing Fuzzy Graphs for Structure-Based Comparison of Protein Pockets
- (2010) Felix Reisen et al. JOURNAL OF PROTEOME RESEARCH
- Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization
- (2010) Sarah R. Langdon et al. Molecular Informatics
- Stochastic Proximity Embedding: Methods and Applications
- (2010) Dimitris K. Agrafiotis et al. Molecular Informatics
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Virtual screening: an endless staircase?
- (2010) Gisbert Schneider NATURE REVIEWS DRUG DISCOVERY
- Efficient Drug Lead Discovery and Optimization
- (2009) William L. Jorgensen ACCOUNTS OF CHEMICAL RESEARCH
- The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian α-carbonic anhydrase isoforms
- (2009) Seppo Parkkila et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification and Validation of a Potent Type II Inhibitor of Inactive Polo-like Kinase 1
- (2009) Sarah Keppner et al. ChemMedChem
- From Machine Learning to Natural Product Derivatives that Selectively Activate Transcription Factor PPARγ
- (2009) Matthias Rupp et al. ChemMedChem
- Kinase-targeted libraries: The design and synthesis of novel, potent, and selective kinase inhibitors
- (2009) Irini Akritopoulou-Zanze et al. DRUG DISCOVERY TODAY
- Visualizing the drug target landscape
- (2009) Stephen J. Campbell et al. DRUG DISCOVERY TODAY
- Characterization of Activity Landscapes Using 2D and 3D Similarity Methods:Consensus Activity Cliffs
- (2009) Jose L. Medina-Franco et al. Journal of Chemical Information and Modeling
- Binding Site Similarity Analysis for the Functional Classification of the Protein Kinase Family
- (2009) Sarah L. Kinnings et al. Journal of Chemical Information and Modeling
- Thinking outside the flask
- (2009) Stephen Davey NATURE
- Self-Organizing Maps in Drug Discovery: Compound Library Design, Scaffold-Hopping, Repurposing
- (2008) P. Schneider et al. CURRENT MEDICINAL CHEMISTRY
- Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States
- (2008) Irina Kufareva et al. JOURNAL OF MEDICINAL CHEMISTRY
- Voyages to the (un)known: adaptive design of bioactive compounds
- (2008) Gisbert Schneider et al. TRENDS IN BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started